We are live on
!
Find out more
RFCA
R&F Capital Advisors Portfolio holdings
AUM
$387M
This Fund
S&P 500
This Quarter
Est. Return
+1.16%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$284M
AUM Growth
–
Cap. Flow
+$292M
Cap. Flow
% of AUM
103.03%
Top 10 Holdings %
Top 10 Hldgs %
11.46%
Holding
485
New
485
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$7.54M |
| 2 |
Baxter International
BAX
|
+$4.4M |
| 3 |
Salesforce
CRM
|
+$4.1M |
| 4 |
Cisco
CSCO
|
+$3.78M |
| 5 |
Mastercard
MA
|
+$3.45M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.67% |
| 2 | Healthcare | 15.04% |
| 3 | Industrials | 12.21% |
| 4 | Technology | 11.93% |
| 5 | Consumer Discretionary | 11.5% |
Similar funds
MGII
AL
KI
NAM
TM
PAM
IWMPD
IMIM
R&F Capital Advisors's Q4 2016 Portfolio in Review
Q4 2016 is the first quarter with a 13F filing on record for R&F Capital Advisors, which disclosed 485 positions worth $284M. Its ten largest holdings account for 11% of the portfolio.
Its largest position is IVERIC bio, Inc. Common Stock: 253,965 shares worth $1.23M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, followed by Healthcare and Industrials.
- R&F Capital Advisors's largest Q4 2016 buy was IVERIC bio, Inc. Common Stock: 253,965 shares worth $1.23M.
- R&F Capital Advisors's ten largest holdings make up 11% of its $284M portfolio in Q4 2016.
- R&F Capital Advisors disclosed 485 positions in Q4 2016, its first 13F filing on record.
Based on R&F Capital Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.